Covid-19 Vaccine Protocols Reveal That Trials Are Designed To Succeed
- close inspection of the protocols raises surprising concerns.
- These trials seem designed to prove their vaccines work, even if the measured effects are minimal.
- Prevention of infection is not a criterion for success for any of these vaccines.
- the implicit conclusion that the vaccines are not expected to prevent infection, only modify symptoms of those infected.
- Moderna, Pfizer, and AstraZeneca—do not require that their vaccine prevent serious disease only that they prevent moderate symptoms
- These vaccine trials are testing to prevent common cold symptoms.
- One of the more immediate questions a trial needs to answer is whether a vaccine prevents infection. If someone takes this vaccine, are they far less likely to become infected with the virus? These trials all clearly focus on eliminating symptoms of Covid-19, and not infections themselves. Asymptomatic infection is listed as a secondary objective in these trials when they should be of critical importance.
- These protocols do not emphasize the most important ramifications of Covid-19 that people are most interested in preventing: overall infection, hospitalization, and death. It boggles the mind and defies common sense that the National Institute of Health, the Center for Disease Control, the National Institute of Allergy and Infectious Disease, and the rest would consider the approval of a vaccine that would be distributed to hundreds of millions on such slender threads of success.